1 citations · 1 across the 1 of their papers we have counts for
1 paper
Peng Yang, Daniel Li, Ruitao Lin +2
The conventional more-is-better dose selection paradigm, which targets the maximum tolerated dose (MTD), is not suitable for the development of targeted therapies and immunotherapi…